Can AstraZeneca's Expanding Cancer Portfolio Sustain Momentum?

Assessing Daiichi Sankyo Company (TSE:4568) Valuation After Recent Share Price Weakness

A Spanish biotech banks $87M to make differentiated ADCs

OpenFold Consortium Adds Eleven New Members as Momentum Builds for Open AI Infrastructure in Biology and Drug Discovery

Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy

Enhertu® Approved in the EU as First Tumor Agnostic HER2 Directed Therapy and Antibody Drug Conjugate for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors

AstraZeneca's Enhertu Wins EU Nod for HER2-Positive Solid Tumors

AstraZeneca's Enhertu Wins EU Nod for HER2-Positive Solid Tumors (Revised)

Sector Update: Healthcare Stocks Lower Wednesday Afternoon

Sector Update: Healthcare Stocks Decline Late Afternoon